Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             53 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Animal use of antimicrobials: impact on resistance Stöhr, Klaus
2000
21-22 4 p. 207-209
3 p.
artikel
2 Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trials Mross, Klaus
2000
21-22 4 p. 223-235
13 p.
artikel
3 Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment Hancock, Robert E.W.
2000
21-22 4 p. 247-255
9 p.
artikel
4 Anticancer therapeutics: “Addictive” targets, multi-targeted drugs, new drug combinations Broxterman, Henk J.
2005
21-22 4 p. 183-197
15 p.
artikel
5 Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance Gonen, Nitzan
2012
21-22 4 p. 183-210
28 p.
artikel
6 Antifungal treatment in pediatric patients Zaoutis, Theoklis E.
2005
21-22 4 p. 235-245
11 p.
artikel
7 Bacterial energetics and antimicrobial resistance Proctor, Richard A.
1998
21-22 4 p. 227-235
9 p.
artikel
8 Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Dai, Tianhong
2012
21-22 4 p. 223-236
14 p.
artikel
9 Can the heat shock protein 90 inhibitor geldanamycin be designed to specifically inhibit HER-2 tyrosine kinase? Neckers, Leonard M.
2000
21-22 4 p. 203-205
3 p.
artikel
10 Caspofungin: the first in a new class of antifungal agents Kartsonis, Nicholas A
2003
21-22 4 p. 197-218
22 p.
artikel
11 Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it? Jung, Laura L.
2001
21-22 4 p. 273-288
16 p.
artikel
12 Chemotherapy of respiratory viruses: prospects and challenges Wyde, Philip R.
1999
21-22 4 p. 244-258
15 p.
artikel
13 Clinical cancer research 2001: new agents and therapies Verweij, Jacob
2001
21-22 4 p. 217-223
7 p.
artikel
14 Clinical cancer research 2000: new agents and therapies Vries, E.G.E.de
2000
21-22 4 p. 197-201
5 p.
artikel
15 Differential effects of cell cycle regulatory protein p21WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy Liu, Suxing
2003
21-22 4 p. 183-195
13 p.
artikel
16 Disrupting the p53-mdm2 interaction as a potential therapeutic modality Moll, Ute M.
2000
21-22 4 p. 217-221
5 p.
artikel
17 Do Fanconi anemia genes control cell response to cross-linking agents by modulating cytochrome P-450 reductase activity? Kruyt, Frank A.E.
2000
21-22 4 p. 211-215
5 p.
artikel
18 Drug resistance and the microenvironment: nature and nurture Morin, Patrice J
2003
21-22 4 p. 169-172
4 p.
artikel
19 Drug resistance in Cryptococcus neoformans Perfect, John R.
1999
21-22 4 p. 259-269
11 p.
artikel
20 Drug resistance in Leishmania: similarities and differences to other organisms Papadopoulou, Barbara
1998
21-22 4 p. 266-278
13 p.
artikel
21 Drug resistance updates meetings-courses-workshops 2003
21-22 4 p. 225-230
6 p.
artikel
22 Editorial Board 2003
21-22 4 p. i-
1 p.
artikel
23 Editorial Board 2005
21-22 4 p. i-
1 p.
artikel
24 Editorial Board 2012
21-22 4 p. i-
1 p.
artikel
25 HIV protease inhibitors as new treatment options for Kaposi’s sarcoma Barillari, Giovanni
2003
21-22 4 p. 173-181
9 p.
artikel
26 Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii Karah, Nabil
2012
21-22 4 p. 237-247
11 p.
artikel
27 Intraperitoneal chemotherapy for ovarian cancer: a question of feasibility? Willemse, Pax H.B.
2003
21-22 4 p. 165-167
3 p.
artikel
28 β-Lactamase induction and cell wall recycling in gram-negative bacteria Wiedemann, Bernd
1998
21-22 4 p. 223-226
4 p.
artikel
29 Literature highlights:Infectious disease drug resistance: summaries of recent papers 2003
21-22 4 p. 219-223
5 p.
artikel
30 Literature Highlights: Recent research in infectious disease drug resistance 2005
21-22 4 p. 259-264
6 p.
artikel
31 Lysosomes and endoplasmic reticulum: Targets for improved, selective anticancer therapy Linder, Stig
2005
21-22 4 p. 199-204
6 p.
artikel
32 Meetings Calendar 1999
21-22 4 p. 277-280
4 p.
artikel
33 MEETINGS CALENDAR 2000
21-22 4 p. 257-261
5 p.
artikel
34 Metastases and their microenvironments: linking pathogenesis and therapy Sierra, Angels
2005
21-22 4 p. 247-257
11 p.
artikel
35 Multiple resistance mechanisms to azole antifungals in yeast clinical isolates Sanglard, Dominique
1998
21-22 4 p. 255-265
11 p.
artikel
36 New approaches to reverse resistance to hormonal therapy in human breast cancer Weinberg, Olga K.
2005
21-22 4 p. 219-233
15 p.
artikel
37 NF- κ B and chemoresistance: could NF- κ B be an antitumor target? Bentires-Alj, Mohamed
1999
21-22 4 p. 274-276
3 p.
artikel
38 NF- κ B and chemoresistance: potentiation of cancer drugs via inhibition of NF- κ B Cusack, James C.
1999
21-22 4 p. 271-273
3 p.
artikel
39 [No title] Kuritzkes, Daniel R.
1998
21-22 4 p. 279-280
2 p.
artikel
40 Overuse of antibiotics for acute respiratory illnesses and the epidemic of penicillin-resistant Streptococcus Pneumoniae Gonzales, Ralph
1998
21-22 4 p. 221-222
2 p.
artikel
41 Perspectives for combination therapy to overcome drug-resistant multiple myeloma Catley, Laurence
2005
21-22 4 p. 205-218
14 p.
artikel
42 Potential and caveats of TRAIL in cancer therapy Held, Jürgen
2001
21-22 4 p. 243-252
10 p.
artikel
43 Proteasome inhibitors as potential novel anticancer agents Dou, Q.Ping
1999
21-22 4 p. 215-223
9 p.
artikel
44 Recent insights into platinum drug resistance in cancer Johnson, Steven W.
1998
21-22 4 p. 243-254
12 p.
artikel
45 Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy Fan, Meiyun
2001
21-22 4 p. 253-267
15 p.
artikel
46 Schistosome resistance to praziquantel Fallon, Padraic G.
1998
21-22 4 p. 236-241
6 p.
artikel
47 Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors Queiroz, Karla C.S.
2012
21-22 4 p. 211-222
12 p.
artikel
48 34th annual meeting of the american society of oncology (ASCO) Los Angeles, California, USA, 16–19 May 1998 de Vries, Elisabeth G.E.
1998
21-22 4 p. 281-283
3 p.
artikel
49 The cost of antibiotic resistance from a bacterial perspective Björkman, Johanna
2000
21-22 4 p. 237-245
9 p.
artikel
50 The role of Fas and FasL as mediators of anticancer chemotherapy Poulaki, Vassiliki
2001
21-22 4 p. 233-242
10 p.
artikel
51 The role of pro-drug therapy in the treatment of cancer Ferguson, Michelle J.
2001
21-22 4 p. 225-232
8 p.
artikel
52 Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs Ackland, Stephen P.
1999
21-22 4 p. 205-214
10 p.
artikel
53 Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic options Malathum, Kumthorn
1999
21-22 4 p. 224-243
20 p.
artikel
                             53 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland